GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 34.35
-2.35 (-6.40%)
At close: Aug 21, 2026
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 14.05 billion as of August 21, 2026. Its market cap has increased by 91.88% in one year.
Market Cap
14.05B
Enterprise Value
13.24B
Revenue
878.13M
Ranking
n/a
PE Ratio
76.06
Stock Price
34.35
ChartMarket Cap Chart
Since April 25, 2022, GemPharmatech's market cap has increased from 7.59B to 14.05B, an increase of 85.21%. That is a compound annual growth rate of 15.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 14.05B | 123.07% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BrightGene Bio-Medical Technology | 16.91B |
| Acrobiosystems | 16.16B |
| HitGen | 15.51B |
| Anhui Anke Biotechnology (Group) | 14.95B |
| Mabwell (Shanghai) Bioscience | 14.48B |
| Sino Biological,Inc. | 14.45B |
| Jinyu Bio-technology | 13.79B |
| Shanghai Medicilon | 13.22B |